Angiotensin (1−7) peptide replacement therapy with plasma transfusion in COVID-19

AIM: To determine whether convalescent angiotensin (1−7) peptide replacement therapy with plasma (peptide plasma) transfusion can be beneficial in the treatment of critically ill patients with severe coronavirus 2 (SARS-CoV-2) infection. STUDY DESIGN: Case series of 9 critically ill patients with la...

Descripción completa

Detalles Bibliográficos
Autores principales: Onal, Hasan, Ergun, Nurcan Ucuncu, Arslan, Bengu, Topuz, Seyma, Semerci, Seda Yilmaz, Ugurel, Osman Mutluhan, Topuzogullari, Murat, Kalkan, Ali, Yoldemir, Sengul Aydin, Suner, Nurettin, Kocatas, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917875/
https://www.ncbi.nlm.nih.gov/pubmed/35305923
http://dx.doi.org/10.1016/j.transci.2022.103418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917875/
https://www.ncbi.nlm.nih.gov/pubmed/35305923
http://dx.doi.org/10.1016/j.transci.2022.103418

Ejemplares similares